Explore 3 Stock Ideas & Industry Insights Download Free Report
• Daniel Thwaites PLC (THW) appeared among the UK’s top equity gainers in a recent session, with a daily price advance of 10.50 per cent to a last traded price of 112.88 GBX, though no confirmed public catalyst has been identified for the move.
Unlike mature pharmaceutical companies that generate recurring commercial revenue, Hemogenyx's investment case is primarily driven by research progress, clinical development, intellectual property, regulatory milestones, and the long-term commercial potential of its therapeutic pipeline. As a result, the company offers significant growth opportunities but also …
Although biotechnology companies typically experience periods of elevated volatility, Avacta continues to attract attention due to the long-term commercial potential of its proprietary platforms and expanding clinical pipeline.
• Futura Medical plc shares declined 12.85% on 26 June 2026, making it one of the notable FTSE AIM losers.
• TheraCryf PLC shares declined 8.51% on 26 June 2026, making it one of the notable FTSE AIM healthcare losers.
• Sareum Holdings plc shares fell 8.70% on 26 June 2026, making it one of the notable FTSE AIM decliners.
• Profit-taking and weak sentiment across speculative AIM biotechnology shares contributed to selling pressure.
• Profit-taking and weak sentiment across speculative AIM biotechnology shares contributed to selling pressure.
• Profit-taking across healthcare growth stocks and weaker AIM market sentiment pressured the shares.
• Investors booked profits amid weaker sentiment across AIM-listed healthcare shares.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…